The major factors driving the growth of the HTS market include initiatives undertaken by pharmaceutical and biotechnology companies, increasing R&D spending, technological advancements in HTS, and the availability of government funding and venture capital investments.
The High Throughput Screening Market is
expected to reach USD 29.29 billion by 2027 from an estimated USD 14.95 billion
in 2019, at a CAGR of 7.8%.
Download PDF Brochure:-https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=134981950
Market Segmentation: -
On the basis of product
and service, the reagents & assay kits segment accounted for the largest
share of the global HTS market. The large share of this segment can be
attributed to factors such as the large numbers of reagents and assay kits used
in HTS techniques, rising prevalence of a number of diseases, increasing
pharmaceutical R&D, and increased government funding for life science
research.
Based on technology, the
High Throughput Screening Industry is segmented into cell-based assays,
lab-on-a-chip (LOC), ultra-high-throughput screening (uHTS), label-free
technology, and bioinformatics. In 2018, the cell-based assays segment
accounted for the largest share of the HTS market.
Based on end user, the
pharmaceutical and biotechnology companies segment accounted for the largest
share of the High Throughput Screening Industry.
Key Market Drivers: –
1 Growing Adoption of Open Innovation Models in Pharmaceutical and
Biotechnology Companies
2 Government Funding and Venture Capital Investments
3 Increasing R&D Spending
4 Technological Advancements
Regional Analysis: -
North America accounted
for the largest share of the HTS market in 2018, followed by Europe and Asia
Pacific.
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=134981950
Top key Players: -
The prominent players in
the global HTS market are Agilent (US), Danaher (US), Thermo Fisher Scientific
(US), PerkinElmer (US), Tecan (Switzerland), Axxam (Italy), Merck Group
(Germany), Bio-Rad (US), Hamilton (US), Corning (US), BioTek (US), and Aurora
Biomed (Canada).
No comments:
Post a Comment